Genentech, the U.S. biotech arm of Swiss pharma giant Roche (RHHBY), announced Tuesday that its drug candidate ocrelizumab had succeeded in cutting the relapse rate for multiple-sclerosis patients in two late-stage trials. The goal of the studies was to show ocrelizumab is significantly superior to Rebif, a form of interferon sold by Pfizer (PFE). Genentech said it had succeeded in this, and also reduced the lesions in the brain associated with
Europe’s wireless service providers will stop charging customers cross-border roaming fees starting in June 2017, and Internet service providers will operate under Open Internet rules after the European Union on Tuesday hammered out a last-minute deal. Europe’s new telecom regulations had been expected, though an agreement was delayed amid intense lobbying by Deutsche Telekom (DTEGY) and others. Europe has been heading down a less stringent path
Security experts liken the race to create the best Internet of Things devices to the California Gold Rush. As in any heady time, the rush needs a marshal — in this case, strong security software and services. “Everyone is trying to be the next webcam or connected thermostat,” said Andrew Hay, director of security research for Internet security firm OpenDNS. “It’s such a fast race that security is often an afterthought. If you’re running neck and